Enhancement of phorbol ester-induced production of tumor necrosis factor alpha by thalidomide

Biochem Biophys Res Commun. 1994 Mar 15;199(2):455-60. doi: 10.1006/bbrc.1994.1250.

Abstract

The effect of thalidomide [racemic (DL-) form and optically pure (D- and L-) forms] on tumor necrosis factor (TNF) alpha production by human leukemia cell lines (HL-60, K562 and U937) stimulated with 12-O-tetradecanoylphorbol-13-acetate (TPA) was investigated. Though thalidomide has been regarded as a specific inhibitor of TNF-alpha production, our study indicated that all forms of thalidomide enhanced (but did not inhibit) the TPA-induced TNF-alpha production by the human leukemia cell lines investigated. The effects of thalidomide on TNF-alpha production might be cell type-specific.

MeSH terms

  • Cell Line
  • Drug Synergism
  • Humans
  • Kinetics
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Leukemia, Promyelocytic, Acute
  • Lymphoma, Large B-Cell, Diffuse
  • Tetradecanoylphorbol Acetate / pharmacology*
  • Thalidomide / pharmacology*
  • Tumor Cells, Cultured
  • Tumor Necrosis Factor-alpha / biosynthesis*

Substances

  • Tumor Necrosis Factor-alpha
  • Thalidomide
  • Tetradecanoylphorbol Acetate